I agree that this site is using cookies. You can find further informations here.
X
Symmans, W Fraser
167  results:
OpenAccess-fulltext X
Search for persons X
?
1

Quantifying hormone receptor status in lobular breast cance..:

Clelland, Elle N ; Rothschild, Harriet T ; Patterson, Anne...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505592/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Clinical significance and biology of circulating tumor DNA ..:

Magbanua, Mark Jesus M ; Brown Swigart, Lamorna ; Ahmed, Ziad...
qt6g68j14c.  , 2023
Link: https://escholarship.org..
 
?
3

Predictors of success in establishing orthotopic patient-de..:

Echeverria, Gloria V ; Cai, Shirong ; Tu, Yizheng...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831981/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

HER-2 low status in early-stage invasive lobular carcinoma ..:

Rothschild, Harriet T ; Clelland, Elle ; Patterson, Anne...
qt2fg1h6pc.  , 2023
Link: https://escholarship.org..
 
?
5

Protein signaling and drug target activation signatures to ..:

Gallagher, Rosa I ; Wulfkuhle, Julia ; Wolf, Denise M...
qt24h2d7g1.  , 2023
Link: https://escholarship.org..
 
?
6

Molecular testing opportunities on cytology effusion specim..:

Sura, Gloria H ; Tran, Kevin ; Fu, Chunxiao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644714/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Protein signaling and drug target activation signatures to ..:

Gallagher, Rosa I ; Wulfkuhle, Julia ; Wolf, Denise M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772394/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Evaluation of the Sensitivity to Endocrine Therapy Index an..:

Speers, Corey W ; Symmans, W. Fraser ; Barlow, William E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082279/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Redefining breast cancer subtypes to guide treatment priori..:

Wolf, Denise M ; Yau, Christina ; Wulfkuhle, Julia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426306/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Residual cancer burden after neoadjuvant chemotherapy and l..:

Yau, Christina ; Osdoit, Marie ; van der Noordaa, Marieke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455620/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Safety and efficacy of HSP90 inhibitor ganetespib for neoad..:

Lang, Julie E ; Forero-Torres, Andres ; Yee, Douglas...
qt6gs8z1df.  , 2022
Link: https://escholarship.org..
 
?
12

Redefining breast cancer subtypes to guide treatment priori..:

Wolf, Denise M ; Yau, Christina ; Wulfkuhle, Julia...
qt1mj7t4r1.  , 2022
Link: https://escholarship.org..
 
?
13

Residual cancer burden after neoadjuvant chemotherapy and l..:

Yau, Christina ; Osdoit, Marie ; van der Noordaa, Marieke...
qt0f60710w.  , 2022
Link: https://escholarship.org..
 
?
14

Evaluation of sensitivity to endocrine therapy index (SET2,..:

Suman, Vera J ; Du, Lili ; Hoskin, Tanya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357183/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Challenges and Gaps in Clinical Trial Genomic Data Manageme..:

Asad, Sarah ; Kananen, Kathryn ; Mueller, Kurt R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012601/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15